Drug resistance surveillance of Acinetobacter baumannii in Pinggu area from 2011 to 2015
10.3969/j.issn.1673-4130.2016.19.024
- VernacularTitle:某地区2011～2015鲍曼不动杆菌耐药监测
- Author:
Yan LI
;
Mingze ZHAO
- Publication Type:Journal Article
- Keywords:
Pinggu area;
Acinetobacter baumannii;
antibiotic resistant
- From:
International Journal of Laboratory Medicine
2016;37(19):2720-2722
- CountryChina
- Language:Chinese
-
Abstract:
Objective To Investigate of drug resistance of Acinetobacter baumannii in Pinggu district from 2011 to 2015 ,and to guide clinical rational use of antibacterial drugs .Methods Retrospective analysis of drug resistance of Acinetobacter baumannii in clinical isolates were performed from 2011 - 2015 .Results From 2011 to 2015 1 744 strains of Acinetobacter baumannii were isola‐ted ,including respiratory specimens (96 .1% ) ,urine (1 .1% ) ,blood (0 .9% ) ,wound (0 .5% ) ,pus (0 .3% ) ,bile (0 .2% ) ,duct (0 .1% ) ,ortherl kinds of secretions (0 .7% ) .The rate of drug resistance to gentamicin ,tobramycin and Amikacin was under 45 .7% .Piperacillin /Tazobactam < 49 .0% ,ampicillin / Sulbactam < 52 .0% ,Imipenem < 50 .0% ,ceftazidime ,cefepime were clos‐en to 50 .0% .To Cefoperazone/Sulbactam ,it increased from 6 .1% to 57 .1% .While ,to Meropenem it increased from 34 .3% to 85 .7% .Conclusion From 2011 to 2015 ,Acinetobacter baumannii infection reduces year by year in our hospital .Pathogenic bacteria mainly comes from the respiratory tract ,urinary tract ,blood ,bile ,and other body fluids .The resistant rate is rising year by year ,to gentamicin ,tobramycin ,amikacin ,Piperacillin/Tazobactam ,Ampicillin/Sulbactam ,Ceftazidime and cefepime ,ciprofloxacin and Imi‐penem .The resistant rate marked increase ,to Cefoperazone/Sulbactam ,Meropenem ,Trimethoprim/Sulfamethoxazole .While ,it de‐creases year by year to minocycline ,tigecycline .
